10–11 May 2016, Catania, Italy
A survival guide for clinicans.
3rd edition.
National Tuberculosis and Leprosy Conrol Programme
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
PLoS ONE 9(1): e87262. doi:10.1371/journal.pone.0087262